329 related articles for article (PubMed ID: 9648772)
1. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.
Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
AJR Am J Roentgenol; 1998 Jul; 171(1):107-13. PubMed ID: 9648772
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
[TBL] [Abstract][Full Text] [Related]
3. [Experimental evaluation of superparamagnetic iron oxide particles in pulmonary MR angiography].
Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
Rofo; 1998 May; 168(5):508-13. PubMed ID: 9617369
[TBL] [Abstract][Full Text] [Related]
4. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
5. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
7. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
[TBL] [Abstract][Full Text] [Related]
9. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
10. MR angiography with blood pool contrast agents.
Bremerich J; Bilecen D; Reimer P
Eur Radiol; 2007 Dec; 17(12):3017-24. PubMed ID: 17639407
[TBL] [Abstract][Full Text] [Related]
11. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
12. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
[TBL] [Abstract][Full Text] [Related]
13. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
Corot C; Violas X; Robert P; Gagneur G; Port M
Invest Radiol; 2003 Jun; 38(6):311-9. PubMed ID: 12908698
[TBL] [Abstract][Full Text] [Related]
15. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide.
Mayo-Smith WW; Saini S; Slater G; Kaufman JA; Sharma P; Hahn PF
AJR Am J Roentgenol; 1996 Jan; 166(1):73-7. PubMed ID: 8571910
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
Dousset V; Ballarino L; Delalande C; Coussemacq M; Canioni P; Petry KG; Caillé JM
AJNR Am J Neuroradiol; 1999 Feb; 20(2):223-7. PubMed ID: 10094342
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
18. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent.
Anzai Y; Prince MR; Chenevert TL; Maki JH; Londy F; London M; McLachlan SJ
J Magn Reson Imaging; 1997; 7(1):209-14. PubMed ID: 9039617
[TBL] [Abstract][Full Text] [Related]
19. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study.
Ahlström KH; Johansson LO; Rodenburg JB; Ragnarsson AS; Akeson P; Börseth A
Radiology; 1999 Jun; 211(3):865-9. PubMed ID: 10352617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]